药品批准更新
Pharmaceutical Approval Update.
作者信息
Kaufman Michele B
出版信息
P T. 2017 Aug;42(8):502-504.
Abstract
Naldemedine (Symproic) for opioid-induced constipation; deutetrabenazine (Austedo) for chorea associated with Huntington's disease; and infliximab-abda (Renflexis), a Remicade biosimilar, for the treatment of Crohn's disease, rheumatoid arthritis, and other diseases.
摘要
纳地美定（Symproic）用于治疗阿片类药物引起的便秘；氘代丁苯那嗪（Austedo）用于治疗与亨廷顿舞蹈病相关的舞蹈症；英夫利昔单抗-abda（Renflexis），一种类克生物仿制药，用于治疗克罗恩病、类风湿性关节炎及其他疾病。
相似文献
1
Pharmaceutical Approval Update.药品批准更新
P T. 2017 Aug;42(8):502-504.
2
The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries.生物类似药英夫利昔单抗（Remsima®）治疗欧洲五国自身免疫性疾病的预算影响
Adv Ther. 2015 Aug;32(8):742-56. doi: 10.1007/s12325-015-0233-1. Epub 2015 Sep 5.
3
Deutetrabenazine for the treatment of Huntington's chorea.曲美他嗪治疗亨廷顿舞蹈病。
Expert Rev Neurother. 2018 Aug;18(8):625-631. doi: 10.1080/14737175.2018.1500178. Epub 2018 Jul 17.
4
Naldemedine (Symproic) for the Treatment Of Opioid-Induced Constipation.纳洛酮（Symproic）用于治疗阿片类药物引起的便秘。
P T. 2018 Oct;43(10):601-627.
5
The nocebo effect challenges the non-medical infliximab switch in practice.在实际应用中，反安慰剂效应给英夫利昔单抗的非医学转换带来了挑战。
Eur J Clin Pharmacol. 2018 May;74(5):655-661. doi: 10.1007/s00228-018-2418-4. Epub 2018 Jan 24.
6
Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.曲美他嗪治疗迟发性运动障碍和亨廷顿舞蹈病相关的舞蹈症：临床试验数据综述。
Expert Opin Pharmacother. 2019 Dec;20(18):2209-2221. doi: 10.1080/14656566.2019.1674281. Epub 2019 Oct 15.
7
8
Deutetrabenazine (Austedo) for Huntington's chorea and tardive dyskinesia.氘代丁苯那嗪（阿速得）用于治疗亨廷顿舞蹈病和迟发性运动障碍。
Med Lett Drugs Ther. 2018 Apr 23;60(1545):65-68.
9
Efficacious transition from reference infliximab to biosimilar infliximab in clinical practice.在临床实践中，从参考用英夫利昔单抗有效地转换为生物类似药英夫利昔单抗。
Int J Rheum Dis. 2019 May;22(5):869-873. doi: 10.1111/1756-185X.13512. Epub 2019 Feb 14.
10
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.氘代丁苯那嗪综述：一种治疗亨廷顿舞蹈症相关舞蹈症的新疗法。
Drug Des Devel Ther. 2018 Feb 15;12:313-319. doi: 10.2147/DDDT.S138828. eCollection 2018.
引用本文的文献
1
New approach methodologies to assess wanted and unwanted drugs-induced immunostimulation.评估所需和不需要药物诱导的免疫刺激的新方法学
Curr Res Toxicol. 2025 Feb 5;8:100222. doi: 10.1016/j.crtox.2025.100222. eCollection 2025.
2
Safety and efficacy of naldemedine in cancer patients with opioid-induced constipation: a pooled, subgroup analysis of two randomised controlled studies.纳地美定用于阿片类药物引起便秘的癌症患者的安全性和有效性：两项随机对照研究的汇总亚组分析
ESMO Open. 2019 Jul 31;4(4):e000527. doi: 10.1136/esmoopen-2019-000527. eCollection 2019.
3
Correcting Naldemedine (Symproic) Product Summary.校正纳地美定（Symproic）产品说明书。
P T. 2017 Nov;42(11):683.
Zotero 插件